购物车
全部删除
您的购物车当前为空
EGFR-IN-144 (Compound 4B) 对EGFR (IC50=0.639 µg/mL) 和微管蛋白聚合 (tubulin polymerization, IC50=7.339 µg/mL) 展现出显著的抑制活性。它在多种癌细胞中表现出细胞毒性,GI50达到纳摩尔水平,并且能够下调 mTOR、TNF-α 和 IL-6 的表达,在 G1/S 期阻止细胞周期并诱导细胞凋亡 (apoptosis)。

EGFR-IN-144 (Compound 4B) 对EGFR (IC50=0.639 µg/mL) 和微管蛋白聚合 (tubulin polymerization, IC50=7.339 µg/mL) 展现出显著的抑制活性。它在多种癌细胞中表现出细胞毒性,GI50达到纳摩尔水平,并且能够下调 mTOR、TNF-α 和 IL-6 的表达,在 G1/S 期阻止细胞周期并诱导细胞凋亡 (apoptosis)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
EGFR-IN-144 相关产品
| 产品描述 | EGFR-IN-144 (Compound 4B) inhibits EGFR (IC50=0.639 µg/mL) and tubulin polymerization (IC50=7.339 µg/mL). It exhibits cytotoxicity in various cancer cells with a GI50 at the nanomolar level. EGFR-IN-144 reduces the expression of mTOR, TNF-α, and IL-6, causes G1/S phase cell cycle arrest, and induces apoptosis. |
| 分子量 | 418.273 |
| 分子式 | C20H17Cl2N3O3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容